Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference

2008-11-25 15:28:03 -

www.optimerpharma.com - Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) is scheduled to present at the 20th Annual Piper Jaffray Health Care Conference at The New York Palace in New York City on December 2, 2008, 12:00 p.m. Eastern Time.
A live audio webcast of this presentation will be accessible on the Company"s website at cts.businesswire.com/ct/CT"id=smartlink&url=http%3A%2F%2Fwww .., under the investors section. A replay of this presentation will be available at the same location for thirty days following the meeting.
About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. OPT-80 is the only antibiotic therapy currently under Phase 3 worldwide development for Clostridium difficile infection. Prulifloxacin is an antibiotic being developed for the treatment of travelers" diarrhea, a form of infectious diarrhea. Additional information can be found at http://http://cts.businesswire.com/ct/CT"id=smartlink&url=http%3A%2F%2Fwww.optimerpharma.com&esheet=5839471&lan=en_US&anchor=www.optimerpharma.com&index=2.


Optimer Pharmaceuticals, Inc.

Christina Donaghy, Corporate Communications Manager

John D. Prunty, Chief Financial Officer & VP Finance

858-909-0736

or

Porter Novelli Life Sciences

Jason I. Spark, Vice President

619-849-6005